Discovery on Target将于会期中举办技能培训讲座。培训讲座针对未于主会议、座谈会、会前研讨会讨论的专业领域，提供深入培训跟指导。研讨会以研究面、业务面、以及有助个人发展的议题为重点。
TS2: INTRODUCTION TO SMALL MOLECULE DRUG DISCOVERY AND DEVELOPMENT
Instructor: H. James Harwood Jr., PhD, Founder and CEO, Delphi BioMedical Consultants, LLC
This 1.5-day lecture-based interactive seminar focuses on strategies for identifying drug discovery targets, discovering and characterizing small molecule hits, and developing structure-activity relationships to advance hits through lead optimization, preclinical development, and clinical evaluation. Participants will learn the stages and processes required to advance programs from idea to clinic, through examples and case studies. This seminar is intended for scientists in either academia or industry who would like to become more familiar with small molecule drug discovery and development.
Each CHI Training Seminar offers 1.5 Days of instruction with start and stop times for each day shown above and on the Event-at-a-Glance published in the onsite Program & Event Guide. Training Seminars will include morning and afternoon refreshment breaks, as applicable, and lunch will be provided to all registered attendees on the full day of the class.
Each person registered specifically for the Training Seminar will be provided with a hard copy handbook for the Seminar in which they are registered. A limited number of additional handbooks will be available for other delegates who wish to attend the Seminar, but after these have been distributed no additional books will be available.
Though CHI encourages track hopping between conference programs, we ask that Training Seminars not be disturbed once they have begun. In the interest of maintaining the highest quality learning environment for Training Seminar attendees, and because Seminars are conducted differently than conference programming, we ask that attendees commit to attending the entire program, and NOT engaging in track hopping, as to not disturb the hands-on style instruction being offered to the other participants.